Literature DB >> 1440764

Innate resistance to new antimalarial drugs in Plasmodium falciparum from Nigeria.

A M Oduola1, A Sowunmi, W K Milhous, D E Kyle, R K Martin, O Walker, L A Salako.   

Abstract

The rapid dissemination of chloroquine-resistant Plasmodium falciparum in West Africa has been well documented and represents a significant health threat to autochthonous populations. The methodical development of alternative chemotherapeutic agents demands that dispensing new antimalarial drugs (mefloquine, halofantrine, and artemisinine [qinghaosu]) be closely monitored in order to protect their clinical utility. Indeed, mefloquine-resistant strains of P. falciparum have been reported. We present data from experiments in vitro on the innate resistance of P. falciparum isolates to mefloquine as well as a disturbing observation of transient resistance to artemisinine. The implications for the extended efficacy of these new antimalarial drugs are addressed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1440764     DOI: 10.1016/0035-9203(92)90533-i

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  10 in total

1.  Pfmdr1 alleles and response to ultralow-dose mefloquine treatment in Gabonese patients.

Authors:  Denise P Mawili-Mboumba; Jürgen F J Kun; Bertrand Lell; Peter G Kremsner; Francine Ntoumi
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

2.  Therapeutic efficacies of artemisinin-based combination therapies in Nigerian children with uncomplicated falciparum malaria during five years of adoption as first-line treatments.

Authors:  Grace O Gbotosho; Akintunde Sowunmi; Christian T Happi; Titilope M Okuboyejo
Journal:  Am J Trop Med Hyg       Date:  2011-06       Impact factor: 2.345

3.  Selection of Plasmodium falciparum multidrug resistance gene 1 alleles in asexual stages and gametocytes by artemether-lumefantrine in Nigerian children with uncomplicated falciparum malaria.

Authors:  C T Happi; G O Gbotosho; O A Folarin; A Sowunmi; T Hudson; M O'Neil; W Milhous; D F Wirth; A M J Oduola
Journal:  Antimicrob Agents Chemother       Date:  2008-12-15       Impact factor: 5.191

4.  In vitro effects of artemisinin ether, cycloguanil hydrochloride (alone and in combination with sulfadiazine), quinine sulfate, mefloquine, primaquine phosphate, trifluoperazine hydrochloride, and verapamil on Toxoplasma gondii.

Authors:  E Holfels; J McAuley; D Mack; W K Milhous; R McLeod
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

Review 5.  Progress in the research of artemisinin-related antimalarials: an update.

Authors:  H J Woerdenbag; N Pras; W van Uden; T E Wallaart; A C Beekman; C B Lugt
Journal:  Pharm World Sci       Date:  1994-08-05

Review 6.  Discovery, mechanisms of action and combination therapy of artemisinin.

Authors:  Liwang Cui; Xin-zhuan Su
Journal:  Expert Rev Anti Infect Ther       Date:  2009-10       Impact factor: 5.091

Review 7.  Enhancing the antimalarial activity of artesunate.

Authors:  J O Adebayo; H Tijjani; A P Adegunloye; A A Ishola; E A Balogun; S O Malomo
Journal:  Parasitol Res       Date:  2020-07-07       Impact factor: 2.289

Review 8.  Antimalarial Drug Resistance: Literature Review and Activities and Findings of the ICEMR Network.

Authors:  Liwang Cui; Sungano Mharakurwa; Daouda Ndiaye; Pradipsinh K Rathod; Philip J Rosenthal
Journal:  Am J Trop Med Hyg       Date:  2015-08-10       Impact factor: 2.345

9.  Efficacy of artemisinin-based combination treatments of uncomplicated falciparum malaria in under-five-year-old Nigerian children.

Authors:  Stephen Oguche; Henrietta U Okafor; Ismaila Watila; Martin Meremikwu; Philip Agomo; William Ogala; Chimere Agomo; Godwin Ntadom; Olajide Banjo; Titilope Okuboyejo; Gboye Ogunrinde; Friday Odey; Olugbemiga Aina; Tolulope Sofola; Akintunde Sowunmi
Journal:  Am J Trop Med Hyg       Date:  2014-09-22       Impact factor: 2.345

10.  Declining responsiveness of childhood Plasmodium falciparum infections to artemisinin-based combination treatments ten years following deployment as first-line antimalarials in Nigeria.

Authors:  Akintunde Sowunmi; Godwin Ntadom; Kazeem Akano; Folasade O Ibironke; Adejumoke I Ayede; Chimere Agomo; Onikepe A Folarin; Grace O Gbotosho; Christian Happi; Stephen Oguche; Henrietta U Okafor; Martin Meremikwu; Philip Agomo; William Ogala; Ismaila Watila; Olugbenga Mokuolu; Finomo Finomo; Joy C Ebenebe; Nma Jiya; Jose Ambe; Robinson Wammanda; George Emechebe; Wellington Oyibo; Francis Useh; Temitope Aderoyeje; Titilope M Dokunmu; Omobolaji T Alebiosu; Sikiru Amoo; Oluwabunmi K Basorun; Olubunmi A Wewe; Chukwuebuka Okafor; Odafe Akpoborie; Bayo Fatunmbi; Elsie O Adewoye; Nnenna M Ezeigwe; Ayoade Oduola
Journal:  Infect Dis Poverty       Date:  2019-08-06       Impact factor: 4.520

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.